However, two recent papers reported on the correlation of ADAM10 with survival in HER2-positive breast cancer [49], and NRG-1b-HER3-HER2 signaling was shown to promote trans-endothelial migration of breast cancer cell lines [50]. This evidence concerns the gene ERBB2 and breast carcinoma.